Nord/LB Reiterates “€132.00” Price Target for Carl Zeiss Meditec (ETR:AFX)

Share on StockTwits

Nord/LB set a €132.00 ($153.49) target price on Carl Zeiss Meditec (ETR:AFX) in a research report released on Wednesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

AFX has been the topic of several other research reports. Kepler Capital Markets set a €80.00 ($93.02) price objective on Carl Zeiss Meditec and gave the stock a sell rating in a report on Monday, February 10th. Berenberg Bank set a €114.00 ($132.56) price objective on Carl Zeiss Meditec and gave the stock a neutral rating in a report on Thursday, January 23rd. HSBC set a €109.00 ($126.74) price objective on Carl Zeiss Meditec and gave the stock a neutral rating in a report on Tuesday, December 10th. DZ Bank restated a neutral rating on shares of Carl Zeiss Meditec in a report on Tuesday, December 10th. Finally, Deutsche Bank set a €140.00 ($162.79) price objective on Carl Zeiss Meditec and gave the stock a buy rating in a report on Tuesday. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company’s stock. Carl Zeiss Meditec currently has a consensus rating of Hold and an average price target of €111.14 ($129.24).

ETR AFX opened at €108.90 ($126.63) on Wednesday. The stock’s 50-day moving average price is €115.83 and its two-hundred day moving average price is €106.77. The company has a current ratio of 3.84, a quick ratio of 3.01 and a debt-to-equity ratio of 4.06. The company has a market cap of $9.74 billion and a PE ratio of 57.44. Carl Zeiss Meditec has a 1 year low of €71.25 ($82.85) and a 1 year high of €122.10 ($141.98).

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Recommended Story: Technical Indicators – What is a Golden Cross?

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Somewhat Positive Press Coverage Extremely Likely to Affect Metro Bank  Share Price
Somewhat Positive Press Coverage Extremely Likely to Affect Metro Bank Share Price
Kinder Morgan  Sets New 12-Month High at $22.13
Kinder Morgan Sets New 12-Month High at $22.13
New York Times  Hits New 1-Year High at $39.80
New York Times Hits New 1-Year High at $39.80
Plantronics  Hits New 1-Year Low at $13.83
Plantronics Hits New 1-Year Low at $13.83
iShares S&P 500 Growth ETF  Sets New 52-Week High at $210.33
iShares S&P 500 Growth ETF Sets New 52-Week High at $210.33
Valmont Industries  Hits New 1-Year High at $154.37
Valmont Industries Hits New 1-Year High at $154.37


 
© 2006-2020 Zolmax.